XBiotech
XBIT
39 hedge funds and large institutions have $20.7M invested in XBiotech in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 6 closing their positions.
140% more capital invested
Capital invested by funds: $8.61M → $20.7M (+$12.1M)
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
3.41% more ownership
Funds ownership: 8.03% → 11.44% (+3.4%)
3% more funds holding
Funds holding: 38 → 39 (+1)
26% less call options, than puts
Call options by funds: $23K | Put options by funds: $31K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$4.12M |
| 2 |
Man Group
London,
United Kingdom
|
+$231K |
| 3 |
EF
Empowered Funds
Havertown,
Pennsylvania
|
+$225K |
| 4 |
BlackRock
New York
|
+$125K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$81.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$132K |
| 2 |
Renaissance Technologies
New York
|
-$109K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$82K |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$72K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$68K |
XBIT Hedge Fund Activity: Q2 2023 in Review
39 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q2 2023, worth a combined $20.7M — up 140% from $8.61M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new XBIT positions and 6 closed out — a net gain of 1 holder — while 12 added to existing stakes and 10 trimmed.
The largest buyer was Millennium Management, adding an estimated $4.12M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $132K sold.
- 39 institutional investors held XBiotech (XBIT) as of Q2 2023, up from 38 in Q1 2023.
- Funds reported $20.7M of XBiotech stock for Q2 2023, up 140% quarter-over-quarter.
- 7 funds opened new XBiotech positions in Q2 2023 and 6 closed out, a net change of +1 holder.
- The largest XBiotech buyer in Q2 2023 was Millennium Management, an estimated $4.12M added.
- The largest XBiotech seller in Q2 2023 was Susquehanna International Group, an estimated $132K sold.
Based on aggregated 13F filings for Q2 2023.